Archeon Medical secures financing for EOlife expansion
Bpifrance, BNP Paribas and Caisse d’Epargne back the French ventilation-monitoring company’s international rollout.
Archeon Medical announced a multi-million-euro financing on 27 June 2024 to expand internationally and bring its EOlife ventilation-monitoring technology to new markets. The company named Bpifrance, BNP Paribas and Caisse d’Epargne as the three lead financing partners; it did not disclose an exact amount.
Bpifrance’s contribution falls under the France 2030 programme. The funding supports the Besançon company’s ongoing development and wider adoption of EOlife, which measures the air delivered during manual ventilation and gives feedback to emergency-care teams.
At the time of the announcement, Archeon said EOlife was marketed in more than 15 countries across Europe, the Middle East, Asia-Pacific and North America.
Use of funds
International expansion
EOlife market launches